Immunoglobulin (Post-exposure prophylaxis)
Treatment used for 1 condition
Total Trials
100
Total Participants
300K
Avg Effectiveness
85%
Avg Safety Score
78%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.